Jamieson Wellness, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA4707481046
CAD
34.07
0.16 (0.47%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

42.28 k

Shareholding (Mar 2025)

FII

0.00%

Held by 0 FIIs

DII

99.94%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

High Management Efficiency with a high ROCE of 12.41%

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 15.70%

 
3

Positive results in Jun 25

4

With ROE of 10.50%, it has a fair valuation with a 3.34 Price to Book Value

5

Majority shareholders : Mutual Funds

 
6

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 1,461 Million (Small Cap)

stock-summary
P/E

30.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.82

stock-summary
Return on Equity

10.50%

stock-summary
Price to Book

3.12

Revenue and Profits:
Net Sales:
199 Million
(Quarterly Results - Jun 2025)
Net Profit:
14 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-8.9%
0%
-8.9%
6 Months
-4.91%
0%
-4.91%
1 Year
-9.6%
0%
-9.6%
2 Years
13.0%
0%
13.0%
3 Years
1.88%
0%
1.88%
4 Years
-15.35%
0%
-15.35%
5 Years
-6.25%
0%
-6.25%

Jamieson Wellness, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
15.70%
EBIT Growth (5y)
10.41%
EBIT to Interest (avg)
7.64
Debt to EBITDA (avg)
2.95
Net Debt to Equity (avg)
0.79
Sales to Capital Employed (avg)
0.78
Tax Ratio
31.59%
Dividend Payout Ratio
64.08%
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
12.41%
ROE (avg)
11.77%
Valuation key factors
Factor
Value
P/E Ratio
30
Industry P/E
Price to Book Value
3.15
EV to EBIT
18.61
EV to EBITDA
15.69
EV to Capital Employed
2.18
EV to Sales
2.43
PEG Ratio
0.52
Dividend Yield
NA
ROCE (Latest)
11.71%
ROE (Latest)
10.50%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 1 Schemes (0.06%)

Foreign Institutions

Held by 0 Foreign Institutions (0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 7.74% vs 10.26% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 66.27% vs 15.28% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "199.10",
          "val2": "184.80",
          "chgp": "7.74%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28.40",
          "val2": "24.20",
          "chgp": "17.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.90",
          "val2": "6.80",
          "chgp": "-13.24%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "13.80",
          "val2": "8.30",
          "chgp": "66.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "117.50%",
          "val2": "105.10%",
          "chgp": "1.24%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 8.52% vs 23.53% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 11.09% vs -12.88% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "733.80",
          "val2": "676.20",
          "chgp": "8.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "112.40",
          "val2": "107.70",
          "chgp": "4.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "29.00",
          "val2": "27.60",
          "chgp": "5.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "12.40",
          "val2": "7.90",
          "chgp": "56.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "51.10",
          "val2": "46.00",
          "chgp": "11.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "127.90%",
          "val2": "129.20%",
          "chgp": "-0.13%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
199.10
184.80
7.74%
Operating Profit (PBDIT) excl Other Income
28.40
24.20
17.36%
Interest
5.90
6.80
-13.24%
Exceptional Items
0.00
0.00
Consolidate Net Profit
13.80
8.30
66.27%
Operating Profit Margin (Excl OI)
117.50%
105.10%
1.24%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 7.74% vs 10.26% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 66.27% vs 15.28% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
733.80
676.20
8.52%
Operating Profit (PBDIT) excl Other Income
112.40
107.70
4.36%
Interest
29.00
27.60
5.07%
Exceptional Items
12.40
7.90
56.96%
Consolidate Net Profit
51.10
46.00
11.09%
Operating Profit Margin (Excl OI)
127.90%
129.20%
-0.13%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 8.52% vs 23.53% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 11.09% vs -12.88% in Dec 2023

stock-summaryCompany CV
About Jamieson Wellness, Inc. stock-summary
stock-summary
Jamieson Wellness, Inc.
Pharmaceuticals & Biotechnology
Jamieson Wellness Inc is a Canada-based company, which operates as the health and wellness company. The Company develops, manufactures and markets brand of vitamins and natural health products. The Company offers vitamins, minerals and supplements (VMS) products and certain over-the-counter remedies through Jamieson and LVHS brands, as well as sports nutrition products through Progressive, Precision and Iron Vegan brands. The Company offers manufacturing and product development services on a contract manufacturing basis to select blue-chip consumer health companies and retailers worldwide. Additionally, the Company also offers services to Strategic Partners Business customers, including regulatory advice, new product development and distribution services and industry insights.
Company Coordinates stock-summary
Company Details
1 Adelaide Street East, Suite 2200 , TORONTO CA : M5C 2V9
stock-summary
Tel: 1 416 96000521 416 7055437
stock-summary
Registrar Details